Frontiers | Underlying Molecular Interconnections of the Estrogen Receptor alpha and Associated Factors involved in Breast Cancer Development: the Way to New Therapeutic Approaches - Volume II

Underlying Molecular Interconnections of the Estrogen Receptor alpha and Associated Factors involved in Breast Cancer Development: the Way to New Therapeutic Approaches - Volume II

3,233
Total downloads
10k
Total views and downloads

Articles

EDITORIAL

Published on 14 Jun 2024

Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: the way to new therapeutic approaches, volume II

Philipp Y. Maximov
Guy Leclercq

doi 10.3389/fendo.2024.1427468

558 views

CASE REPORT

Published on 13 Mar 2024

Chemotherapy combined with endocrine neoadjuvant therapy for hormone receptor-positive local advanced breast cancer: a case report and literature review

Nengying Zhang
Chengmin Luo
Jiayang Li
Yuxiang Bao
Zhongliang Yan
Xiaoming Cheng
Taolang Li
Junyuan Lv

Chemotherapy combined with endocrine neoadjuvant therapy for hormone receptor-positive local advanced breast cancer: a case report and literature review

doi 10.3389/fendo.2024.1362725

1,142 views
1 citation

ORIGINAL RESEARCH

Published on 05 Dec 2023

Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade

Dasong Wang
Yan Yang
Lei Yang
Hongwei Yang

Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade

doi 10.3389/fendo.2023.1287101

1,608 views

REVIEW

Published on 30 Aug 2023

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer

Amber J. Kiliti
Ghada M. Sharif
Mary Beth Martin
Anton Wellstein
Anna T. Riegel

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer

doi 10.3389/fendo.2023.1250218

2,698 views
5 citations

ORIGINAL RESEARCH

Published on 18 Apr 2023

A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma

Manuela Cipolletti
Stefano Leone
Stefania Bartoloni
Filippo Acconcia

A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma

doi 10.3389/fendo.2023.1129162

1,996 views
5 citations

Share on

Frontiers in Endocrinology

Frontiers in Endocrinology

Cancer Endocrinology

Impact

10kTopic views
6,617Article views
3,233Article downloads